Robert V Linden Net Worth

The estimated Net Worth of Robert V Linden is at least $699 Thousand dollars as of 5 June 2013. Robert Linden owns over 9,383 units of Lemaitre Vascular Inc stock worth over $565,784 and over the last 17 years Robert sold LMAT stock worth over $133,360.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Robert Linden LMAT stock SEC Form 4 insiders trading

Robert has made over 2 trades of the Lemaitre Vascular Inc stock since 2013, according to the Form 4 filled with the SEC. Most recently Robert sold 9,383 units of LMAT stock worth $60,520 on 5 June 2013.

The largest trade Robert's ever made was selling 11,941 units of Lemaitre Vascular Inc stock on 6 May 2013 worth over $72,840. On average, Robert trades about 547 units every 1 days since 2008. As of 5 June 2013 Robert still owns at least 6,522 units of Lemaitre Vascular Inc stock.

You can see the complete history of Robert Linden stock trades at the bottom of the page.

What's Robert Linden's mailing address?

Robert's mailing address filed with the SEC is C/O LEMAITRE VASCULAR, INC., 63 SECOND AVENUE, BURLINGTON, MA, 01803.

Insiders trading at Lemaitre Vascular Inc

Over the last 18 years, insiders at Lemaitre Vascular Inc have traded over $169,251,022 worth of Lemaitre Vascular Inc stock and bought 22,755 units worth $292,783 . The most active insiders traders include George W Le Maitre, Guido J Neels, and David B Roberts. On average, Lemaitre Vascular Inc executives and independent directors trade stock every 10 days with the average trade being worth of $1,488,890. The most recent stock trade was executed by David B Roberts on 13 August 2024, trading 3,063 units of LMAT stock currently worth $107,236.

What does Lemaitre Vascular Inc do?

lemaitre vascular is a provider of devices and implants for the treatment of peripheral vascular disease, a condition that affects more than 20 million people worldwide. the company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. the company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. the company is listed on nasdaq.

Complete history of Robert Linden stock trades at Lemaitre Vascular Inc

Lemaitre Vascular Inc executives and stock owners

Lemaitre Vascular Inc executives and other stock owners filed with the SEC include:

• George LeMaitre,
  Chairman of the Board, Chief Executive Officer
• David Roberts,
  President, Director
• Joseph Pellegrino,
  Chief Financial Officer, Director
• George W. LeMaitre,
  Chairman & CEO
• Trent Kamke,
  Senior Vice President - Operations
• David B. Roberts,
  Pres & Director
• Joseph P. Pellegrino Jr.,
  CFO, Treasurer, Sec. & Director
• Trent G. Kamke,
  Sr. VP of Operations
• John O'Connor,
  Independent Director
• Lawrence Jasinski,
  Independent Director
• John Roush,
  Independent Director
• Bridget Ross,
  Independent Director
• James Russell,
  Director, Operations
• Helen Goulding,
  Director, Sales - Northern Europe
• Ryan Connelly,
  Vice President - Research & Development
• Xiang Zhang,
  Vice President, Regulatory Affairs
• Jacob Petersen,
  Vice President, Asia-Pac
• Jonathan Ngau,
  Vice President - Information Technology
• Roli Kumar-Choudhury,
  Vice President, Quality Affairs
• Kimberly Cieslak,
  Vice President - Marketing
• Chance Kriesel,
  Vice President - Sales, The Americas
• Giovannella Deiure,
  Vice President, Sales – Southern Europe
• Stephane Maier,
  Vice President, EMEA Operations
• Andrew Hodgkinson,
  Senior Vice President - Clinical, Regulatory and Quality Affairs
• Laurie Churchill,
  Senior Vice President, General Counsel
• Stephane Maier,
  Sr. VP of EMEA Operations
• Andrew Hodgkinson,
  Sr. VP of Clinical, Regulatory & Quality Affairs
• Daniel J. Mumford,
  Director of HR
• Kimberly L. Cieslak,
  VP of Marketing
• Laurie A. Churchill,
  Sr. VP & Gen. Counsel
• Dr. George D. LeMaitre,
  Founder and Chairman of Scientific Advisory Board
• Cornelia W Le Maitre,
  V.P., Human Resources,Director
• Michael T Wijas,
  VP of Sales, The Americas
• Michael H Thomas,
  Director
• Russell D Hays,
  Director
• Aaron M Grossman,
  General Counsel
• William N Jr Thorndike,
  Director
• Equity Investors Lp/Ma Hous...,
  
• George D Le Maitre,
  Director
• Michael C Jackson,
  Director
• Robert V Linden,
  VP, North American Sales
• Peter R Gebauer,
  President, International OP
• Kevin D Kelly,
  V. P. North American Sales
• Maik D Helmers,
  V.P. Central European Sales
• Guido J Neels,
  Director
• David N Gill,
  Director
• Duane M De Sisto,
  Director
• Martha Shadan,
  Director